Harmonization and standardization of tumor markers and liquid biopsies in China: A short perspective
Open Access
- 1 October 2026
- journal article
- Published by SAGE Publications in Tumor Biology
- Vol. 48
Abstract
Circulating tumor markers such as serum carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and carbohydrate antigen (CA) 15-3 are widely used. In recent years, liquid biopsies, including circulating tumor DNA and tumor mutational burden, have been developed. In this review, we describe the status of harmonization and standardization of tumor markers in clinical practice in China, based on a systematic literature search of the CNKI and PubMed databases. Substantial inter-laboratory variability in measurement results persists. Participation in national external quality assessment (EQA) schemes and proficiency testing (PT) has successfully mitigated result discrepancies across different instruments and laboratory procedures during the last decades. Further development and refinement of standardization and harmonization approaches for liquid biopsies remain an unmet need.Keywords
Funding Information
- National Natural Science Foundation of China (82272406)
This publication has 29 references indexed in Scilit:
- Performance evaluation and comparison of ChatGPT, Gemini, Grok, and DeepSeek in the interpretation of tumor marker reportsClinica Chimica Acta, 2026
- Exploring clinical feasibility of zero-shot learning in a large language model for immunofixation electrophoresis image interpretationClinica Chimica Acta, 2026
- Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung CancerJournal of Thoracic Oncology, 2025
- Laboratory practices for next-generation sequencing-based circulating tumor DNA analysis: insights from a comprehensive survey in ChinaVirchows Archiv, 2025
- External quality assessment for detection of colorectal cancer by Septin9 DNA methylation in clinical laboratoriesClinica Chimica Acta, 2023
- Accurate method for value assignment of carcinoembryonic antigen reference materialsJournal of Clinical Laboratory Analysis, 2023
- Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNAClinica Chimica Acta, 2023
- Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and ChinaBreast Cancer Research and Treatment, 2021
- Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSLVirchows Archiv, 2020
- A long way to go for the harmonization of four immunoassays for carcinoembryonic antigenClinica Chimica Acta, 2016